Cart
sales@molnova.com
C-Peptide 1 (rat)
CAS No. 41475-27-8
C-Peptide 1 (rat)( ——— )
Catalog No. M40122 CAS No. 41475-27-8
C-Peptide 1 (rat), a peptide, is aβ-catenin/GSK-3β activator. C-Peptide 1 (rat) can regulate the Wnt/β-catenin signaling pathway. C-Peptide 1 (rat) can be used for the research of cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 223 | In Stock |
|
| 10MG | 357 | In Stock |
|
| 25MG | 588 | In Stock |
|
| 50MG | 817 | In Stock |
|
| 100MG | 1097 | In Stock |
|
| 200MG | 1479 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameC-Peptide 1 (rat)
-
NoteResearch use only, not for human use.
-
Brief DescriptionC-Peptide 1 (rat), a peptide, is aβ-catenin/GSK-3β activator. C-Peptide 1 (rat) can regulate the Wnt/β-catenin signaling pathway. C-Peptide 1 (rat) can be used for the research of cancer.
-
DescriptionC-Peptide 1 (rat), a peptide, is aβ-catenin/GSK-3β activator. C-Peptide 1 (rat) can regulate the Wnt/β-catenin signaling pathway. C-Peptide 1 (rat) can be used for the research of cancer.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number41475-27-8
-
Formula Weight3259.58
-
Molecular FormulaC140H228N38O51
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL (30.68 mM; ultraphonic; ) H2O : 50 mg/mL (15.34 mM; ultraphonic)
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang N, et al. The recent progress of peptide regulators for the Wnt/β-catenin signaling pathway. Front Med (Lausanne). 2023 Jun 16;10:1164656.?
molnova catalog
related products
-
ML179
ML179 is a potent and selective inverse agonist of liver receptor homolog-1 (LRH1, NR5A2) with IC50 of 320 nM.
-
Quazolast
Quazolast (RHC 3988) is a potent mediator release inhibitor used as a control against ragweed antigenic nasal challenge and demonstrates superiority over placebo in preventing nasal congestion and nasal itching following such challenges.
-
Pipoxizine
Pipoxizine has an antagonistic effect on histamine-induced bronchoconstriction and may be used in the study of asthma disease.
